{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:07:11Z","timestamp":1791648431032,"version":"4.3.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.lungcan.2007.07.015","type":"journal-article","created":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T11:24:06Z","timestamp":1188991446000},"page":"407-410","source":"Crossref","is-referenced-by-count":9,"title":["Exacerbated radiodermatitis and bilateral subdural hemorrhage after whole brain irradiation combined with epidermal growth factor receptor tyrosine kinase inhibitors for brain metastases in lung cancer"],"prefix":"10.1016","volume":"59","author":[{"given":"Yu-Jie","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-Jong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yueh","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2007.07.015_bib1","series-title":"The physics of radiation therapy","author":"Khan","year":"2003"},{"key":"10.1016\/j.lungcan.2007.07.015_bib2","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/0360-3016(94)00423-I","article-title":"Pathophysiology of irradiated skin and breast","volume":"31","author":"Archambeau","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2007.07.015_bib3","series-title":"Cancer: principles and practice of oncology","author":"DeVita","year":"2005"},{"key":"10.1016\/j.lungcan.2007.07.015_bib4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0360-3016(94)00655-5","article-title":"Radiation response of the central nervous system","volume":"31","author":"Schultheiss","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2007.07.015_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1634\/theoncologist.10-8-579","article-title":"Current knowledge and future directions of the selective epidermal growth factor receptor inhibitors erlotinib (Tarceva) and gefitinib (Iressa)","volume":"10","author":"Siegel-Lakhai","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.lungcan.2007.07.015_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1634\/theoncologist.10-7-467","article-title":"The current situation: erlotinib (Tarceva) and gefitinib (Iressa) in non-small cell lung cancer","volume":"10","author":"Comis","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.lungcan.2007.07.015_bib7","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1200\/JCO.2006.10.4166","article-title":"Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib","volume":"25","author":"Cho","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2007.07.015_bib8","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1158\/0008-5472.CAN-04-3547","article-title":"Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva)","volume":"65","author":"Chinnaiyan","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2007.07.015_bib9","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ijrobp.2003.09.094","article-title":"Rationale and clinical basis for combining gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumors","volume":"58","author":"Ochs","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2007.07.015_bib10","first-page":"3250","article-title":"Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa)","volume":"8","author":"Bianco","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2007.07.015_bib11","first-page":"2166","article-title":"Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis","volume":"6","author":"Huang","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2007.07.015_bib12","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/ijc.11437","article-title":"Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer","volume":"107","author":"Shintani","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2007.07.015_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1535-6108(03)00333-7","article-title":"An oncogenic tyrosine kinase inhibits DNA repair and DNA-damage-induced Bcl-xL deamidation in T cell transformation","volume":"5","author":"Zhao","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lungcan.2007.07.015_bib14","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1200\/JCO.2005.00.992","article-title":"Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence","volume":"23","author":"Mitsudomi","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2007.07.015_bib15","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1200\/JCO.2005.05.1631","article-title":"Erlotinib induced skin rash spares skin in previous radiotherapy field","volume":"24","author":"Mitra","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500207004217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500207004217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T21:03:17Z","timestamp":1556830997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500207004217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0169500207004217"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2007.07.015","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}